Contact Us
Drug Info Links PDA Software Article Summaries Slide Shows Review Articles What's New

Please Select:
   Hemostatic Drug Info
   Interesting Links
   PDA Software
   Article Summaries
   Slide Shows
   Review Articles
   What's New

Search the site

Broze GJ Jr., Tissue factor pathway inhibitor and the revised theory of coagulation. Annual Review of Medicine. 46:103-12, 1995.
Tissue factor pathway inhibitor (TFPI) is a multivalent, Kunitz-type plasma proteinase inhibitor that regulates tissue factor-induced coagulation. TFPI directly inhibits activated factor X and, in a factor Xa-dependent fashion, produces feedback inhibition of the factor VIIa/tissue factor catalytic complex. The properties of this rediscovered inhibitor appear, at least in part, to explain the clinical requirement for both the extrinsic and intrinsic pathways of the cascade and waterfall theories of blood clotting and have led to a reformulation of the coagulation mechanism. In the revised hypothesis, factor VIIa/tissue factor is responsible for the initiation of coagulation, but owing to TFPI-mediated inhibition, sustained hemostasis requires the persistent and amplified procoagulant action of intrinsic factors VIII, IX, and XI.
© Copyright 2002-2019 ~ All rights reserved.